http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1343407-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C251-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C243-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-15
filingDate 1970-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1974-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1343407-A
titleOfInvention Preparation of l-a-hydrazino-beta-phenylpropionic acid compounds
abstract 1343407 L-α-hydrazino-#-phenylpropionic acid compounds MERCK & CO Inc 17 Dec 1970 [18 Dec 1969 5 Feb 1970 24 Feb 1970 25 March 1970 (9)] 60035/70 Heading C2C L-Compounds containing not more than 10% of the D-form and having the Formula I (in which each of R<SP>1</SP> and R<SP>2</SP> is H, OH, C 1-6 alkoxy, phenoxy or benzyloxy, each of R<SP>3</SP> and R<SP>4</SP> is H or C 1-6 alkyl and R<SP>5</SP> is H, C 1-6 alkyl, a metal atom or, in the case of a multivalent metal, an equivalent of the metal) are prepared from a racemate or other mixture of the D and L-isomers by (a) seeding a saturated solution of the D,L-mixture or an acid addition salt thereof, with crystals of the L-isomer or an acid addition salt thereof and recovering the L-isomer or salt thus precipitated and, if necessary, converting the salt to the acid, or (b) by treating with an optically active isomer of an acylating agent (e.g. l-menthoxy acetyl chloride d-o-acetylatrolactic acid chloride) to produce a diastereoisomeric pair of acylates, separating them and hydrolysing the appropriate diastereoisomer to produce the desired L-diastereoisomer of the starting material, or (c) by treating with an optically active base to produce a diastereoisomeric pair of salts, separating the latter by fractional crystallization and regenerating the acid. Compounds I are useful as decarboxylase inhibitors and antihistaminics.
priorityDate 1970-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394858
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID312
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID556978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416008962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394843

Total number of triples: 19.